Table 3.
Laboratory tests at the time of ECMO initiation.
| Patient | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | Normal value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| GPT (U/L) | 44 | 48 | 70 | 403 | 37 | 21 | 162 | 370 | 63 | 160 | 9–50 |
| GOT (U/L) | 60 | 247 | 166 | 2231 | 137 | 25 | 185 | 419 | 79 | 163 | 15–40 |
| LDH (U/L)) | 515 | 859 | 884 | 2515 | 404 | 497 | 370 | 724 | 482 | 877 | 24–195 |
| TBIL (μmol/L) | 43.3 | 9.6 | 12.4 | 21.9 | 19 | 7.5 | 19 | 4.6 | 3.8 | 11.8 | 3.4–20.5 |
| TB (g/L) | 54.9 | 42 | 52.3 | 34.1 | 61.4 | 49.9 | 64.7 | 24.9 | 49.7 | 53.9 | 65–85 |
| ALB (g/L) | 28.4 | 28 | 28.2 | 16.3 | 35.5 | 28.4 | 44.6 | 14.9 | 24.7 | 28.3 | 40–55 |
| WBC (109/L) | 11.5 | 14.3 | 12.8 | 10.8 | 15.7 | 18.1 | 36.3 | 8.8 | 13.8 | 4.2 | 3.5–9.5 |
| HB (g/L) | 97 | 100 | 114 | 89 | 109 | 75 | 103 | 64 | 81 | 87 | 130–175 |
| PLT (109/L) | 63 | 94 | 100 | 139 | 194 | 159 | 343 | 13 | 333 | 83 | 125–350 |
| INR | 1.07 | 1.54 | 1.1 | 5.12 | 1.11 | 1.02 | 1.44 | 2.31 | 1.26 | 1.41 | 0.8–1.4 |
| APTT (s) | 40.1 | 111.4 | 28.5 | >160 | 34.1 | 38.8 | 36.4 | 117.5 | 111 | 48.3 | 25–31.3 |
| D-D (μg/L) | 2050 | 5400 | 870 | 92530 | 4480 | 4820 | 32630 | 31200 | 6540 | 3680 | |
| CR (μmol/L) | 55 | 64 | 55 | 112 | 84 | 53 | 82 | 76 | 49 | 42 | 41–111 |
| BUN (mmol/L) | 2.63 | 3.16 | 3.09 | 7.1 | 4.27 | 3.45 | 6.18 | 3.74 | 5.94 | 2.53 | 3.1–8.8 |
GPT, glutamic pyruvic transaminase; GOT, glutamic oxaloacetic transaminase; LDH, lactic dehydrogenase; TBIL, total bilirubin; TB, total albumin; ALB, albumin; WBC, white blood cell; HB, hemoglobin; PLT, platelets; INR, international normalized ratio; APTT, activated partial thromboplastin time; D-D, d-dimer; CR, creatinine; BUN, blood urea nitrogen.